InvestorsHub Logo
icon url

Bruinfan4ever

02/13/18 10:30 AM

#217236 RE: noretreat #217233

It's not the results that the market is unimpressed with. The market doesn't know how IPIX will move these trials to phase 3. That's the problem.

You think the market will become impressed with results if and when a deal is announced?

icon url

DaubersUP

02/13/18 10:51 AM

#217242 RE: noretreat #217233

Glad we agree for once.
B-absssi results were comparable to Dapto - I’d say 2 gold increase for success
B-OM - currently zero preventative drugs on market - results were outstanding considering the placebo rate of OM was only 60% which is historically about 10-20% lower than normal. Add the historic rates and the trial results just became SUPER!!!

Prurisol TBD in the next 5 weeks. Anything above 25% PASI 75 would be ideal if safety trumps Otezla and it may work faster....

I’d say we have 3 really good chances of two fold increase to market.